Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar

Seokkyun KimQuality Evaluation Team, Samsung Bioepis, Incheon, South KoreaCorrespondence[email protected]

Jinsu SongQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Seungkyu ParkQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Sunyoung HamQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Kyungyeol PaekQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Minjung KangQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Yunjung ChaeQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Heewon SeoQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Hyung-Chan KimQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Michael FloresQuality Evaluation Team, Samsung Bioepis, Incheon, South Korea

Your download is now in progress and you may close this window